MeiraGTx Holdings plc
MGTX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$10.77
Today
-0.3%
YTD
+36.3%
About
Meiragtx Holdings PLC is a vertically integrated clinical-stage gene therapy company, which researches and develops treatments for serious diseases of the eye, salivary gland, and central nervous system. The company is based in New York and was founded in 2015. Operating in the United States, United Kingdom, and the Netherlands, Meiragtx uses the MGTX ticker on NASDAQ GS. Buy MGTX stock to diversify your investment portfolio.
Price chart
Closing price history for MGTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)15.29
P/S (TTM)2.55
P/B (TTM)4.71
Market cap$1.04B
Cap tierSmall-cap
Industry avg P/E-1.99
Profitability
Gross margin94.90%
EBIT margin45.94%
Net margin50.00%
ROE72.28%
ROA26.54%
Earnings & Revenue
Revenue (TTM)$397.50M
Revenue growth (1Y)+948.3%
EPS (TTM)$0.71
Free cash flow$10.47M
Total debt$112.32M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.39
Employees403
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.